Purpose:
Support policies and research that ensure optimal use of antimicrobials in areas including antimicrobial development, public health, and animal husbandry.
ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting |
Policy and Government Affairs |
SIDP is committed to promoting appropriate use of antimicrobial agents through a variety of activities. SIDP's Policy and Government Affairs Committee focuses efforts on legislative and regulatory matters related to antimicrobial use and resistance. SIDP educates and advocates to various government and private entities both as a standalone organization as well as partnering with other organizations to enact positive change. | For inquiries to SIDP to support regulatory or legislative activities |
What are SIDP's Top Advocacy Priorities? |
SIDP created a position statement on Incentives to Support Antimicrobial Drug Development as a resource to address potential solutions to the ongoing regulatory and economic barriers that we face in the antimicrobial drug development landscape. Link to the full statement here |
|
Recent SIDP Statements & Sign-On Letters Involving Advocacy
- 07/2026 - Joint Response to June 2026 ACIP Charter Changes
-
03/2026 - Fiscal Year 2027 AMR appropriations for antimicrobial resistance
-
03/2026 - Humanitarian Aid Should Never Be a Negotiating Chip
- 02/2026 - Statement of support for AAP's immunization schedule
- 01/2026 - Pharmacy Profession Vaccine Statement
- 12/2025 - Statement from Leading Medical, Health and Patient Advocacy Groups on CDC Vaccine Meeting
- 09/2025 - Joint statement calling for Secretary Kennedy resignation
- 09/2025 - Fiscal Year 2026 appropriations for public health workforce loan repayment and bio-preparedness programs
- 07/2025 - Welcome letter to CDC Director Monarez
- 06/2025 - Letter to FDA Commissioner Makary with the Keeping Antibiotics Working Coalition asking for specific actions to address antibiotic overuse in the food animal industry
- 06/2025 - Letter to HHS Secretary Kennedy to request the President’s Advisory Council on Combating Antibiotic Resistance (PACCARB) meet as soon as possible
- 05/2025 - Fiscal Year 2026 AMR appropriations for antimicrobial resistance
- 04/2025 - Public Health and Bio Preparedness Workforce Pilot Loan Repayment Programs Reauthorization
- 04/2025 - Letter to congress calling for congressional oversight on HHS reorganization to maintain critical functions
SIDP Position Statements
SIDP Statement on Advisory Committee on Immunization Practices (ACIP) Recommendation to End Universal Hepatitis B Vaccine Recommendation for Newborns Published December 2025 Learn More |
SIDP Position on Incentives to Support Antimicrobial Drug Development Published January 2024 Learn More
|
|
SIDP Endorses ASM Position Statement on The Need for Dedicated Microbiology Leadership in the Clinical Microbiology Laboratory Learn More Published February 2021 |
SIDP Endorses SHEA Policy Statement on Routine Immunizations Published July 2020 Learn More |
Essential Role of Pharmacists in Antibiotic Stewardship in Outpatient Care Published September 2018 Learn More
|
Role of Antimicrobial Stewardship Pharmacist in the Use of Rapid Diagnostic Testing in Acute Care Learn More Published April 2018 |
Essential Role of Pharmacists in Antibiotic Stewardship Programs in Long Term Care Facilities Learn More Published October 2016 |
Role of Pharmacists in Antibiotic Stewardship in the Emergency Department Published October 2016 Learn More |
Agricultural Application for Antimicrobials – Official Position Statement Published April 2016 (Update in Progress) Learn More |
Contact | Follow Us
Proudly managed by Affinity Strategies
|
